CorMedix (CRMD) Total Current Liabilities (2010 - 2025)

CorMedix (CRMD) has 15 years of Total Current Liabilities data on file, last reported at $174.3 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 414.98% year-over-year to $174.3 million; the trailing twelve-month figure through Dec 2025 stood at $174.3 million (up 414.98% YoY), and the FY2025 full-year result was $174.3 million, up 414.98% from the prior year.
• Total Current Liabilities rose to $174.3 million in Q4 2025, from $133.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $174.3 million in Q4 2025 to a low of $3.0 million in Q1 2021.
• A 5-year average of $25.8 million and a median of $7.5 million in 2023 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities plunged 47.46% in 2021 and soared 623.14% in 2025, its largest moves.
• Tracing CRMD's Total Current Liabilities over 5 years: stood at $5.3 million in 2021, then climbed by 18.07% to $6.3 million in 2022, then jumped by 80.65% to $11.4 million in 2023, then soared by 196.83% to $33.8 million in 2024, then surged by 414.98% to $174.3 million in 2025.
• Business Quant data shows CRMD's Total Current Liabilities at $174.3 million in Q4 2025, $133.6 million in Q3 2025, and $31.7 million in Q2 2025.